Utilizamos cookies

Este sitio web utiliza cookies propias y de terceros para mantener la sesión, ofrecerle una mejor experiencia de usuario y obtener datos estadísticos de navegación de los usuarios. Para más información vea la Política de cookies.

Ver Investigador - - Prisma - Unidad de Bibliometría

Maria Eva Mingot Castellano

Profesora Asociada CIS
emingot@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin Grupo - 0 ()
Tipo Año Título Fuente
Artículo2024 ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy. The Spanish registry BLOOD
Artículo2024 Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia. GENE THERAPY
Artículo2024 Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons. EXPERT REVIEW OF HEMATOLOGY
Artículo2024 Treatment with fostamatinib in patients with immune thrombocytopenia: Experience from the Andalusian region in Spain—The Fostasur Study BRITISH JOURNAL OF HAEMATOLOGY
Resumen congreso2023 ACQUIRED HAEMOPHILIA HAEMOPHILIA
Revisión2023 An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura EXPERT REVIEW OF HEMATOLOGY
Artículo2023 Autoimmune hemolytic anemia during pregnancy and puerperium: an international multicenter experience BLOOD
Artículo2023 Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81-8973): Final results of the global real-world study, TAURUS EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2023 Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial LANCET
Artículo2023 Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT) BRITISH JOURNAL OF HAEMATOLOGY
Revisión2023 Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI) JOURNAL OF CLINICAL MEDICINE
Revisión2023 Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments TRANSFUSION AND APHERESIS SCIENCE
Letter2023 Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation ANNALS OF HEMATOLOGY
Artículo2023 Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A NEW ENGLAND JOURNAL OF MEDICINE
Resumen congreso2022 Pttapp: An Application Developed By the Spanish Society of Hematology and Hemotherapy to Show Practical Recommendations on the Management of Immune TTP BLOOD
Revisión2022 Acquired Haemophilia A: A Review of What We Know JOURNAL OF BLOOD MEDICINE
Resumen congreso2022 ACQUIRED VON WILLEBRAND DISEASE AND CHRONIC LYMPHOCYTIC LEUKAEMIA: REMISSION AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION HAEMOPHILIA
Artículo2022 Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study EUROPEAN JOURNAL OF HAEMATOLOGY
Resumen congreso2022 Anxiety and Depression in Patients with Haemophilia a without Inhibitors and Their Caregivers Included in Hemolife, Non Interventional Study in the Spanish Population BLOOD
Resumen congreso2022 Autoimmune Hemolytic Anemia during Pregnancy or Post-Partum: An International Multi-Center Experience BLOOD
Revisión2022 COVID-19 Vaccines and Autoimmune Hematologic Disorders Vaccines
Resumen congreso2022 Efficacy of thrombopoietin receptor agonists in Evans syndrome: An international multicentre experience BRITISH JOURNAL OF HAEMATOLOGY
Artículo2022 IX international curse of continuing formation in haemophilia and other congenital coagulopathies. The role of the Laboratory in coagulation disorders. Diagnosis of von Willebrand disease BLOOD COAGULATION & FIBRINOLYSIS
Artículo2022 New treatments for primary immune thrombocytopenia BLOOD COAGULATION & FIBRINOLYSIS
Revisión2022 Novel Therapies to Address Unmet Needs in ITP PHARMACEUTICALS
Artículo2022 Pharmacokinetic and clinical improvements after PK-guided switch from standard half-life to extended half-life factor VIII products THROMBOSIS RESEARCH
Artículo2022 Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura Blood Advances
Artículo2022 Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura MEDICINA CLINICA
Letter2022 Thrombopoietin receptor agonists in adult Evans syndrome: an international multicenter experience BLOOD
Artículo2022 Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A NEW ENGLAND JOURNAL OF MEDICINE
Artículo2021 A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients BLOOD CELLS MOLECULES AND DISEASES
Resumen congreso2021 Contribution of Next Generation Flow (NGF) Cytometry in Primary Immune Thrombocytopenia (ITP): Utility for the Differential Diagnosis with Myelodysplastic Syndromes BLOOD
Resumen congreso2021 Cytopenias in CAR-T Cell Therapy and Use of Transfusion Resources in Adult Patients with Lymphoproliferative Disorders BLOOD
Corrección2021 Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (vol 11, 16867, 2021) Scientific reports
Resumen congreso2021 Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplantation: A Retrospective Analysis BONE MARROW TRANSPLANTATION
Artículo2021 Evans syndrome in adults: an observational multicenter study Blood Advances
Resumen congreso2021 GetEfficacy of Thrombopoietin Receptor Agonists in Evans Syndrome: An International Multicenter Experience BLOOD
Artículo2021 Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain BRITISH JOURNAL OF HAEMATOLOGY
Artículo2021 Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura Journal of Clinical Apheresis
Resumen congreso2021 INCREASE IN THE CONSUMPTION OF PLATELET POOLS IN A 30 LEVEL HOSPITAL: ANALYSIS AND OPTIMIZATION ROUTES HAEMATOLOGICA
Artículo2021 Management of acquired hemophilia A: results from the Spanish registry Blood Advances
Artículo2021 Real-World Rates of Bleeding, Factor VIII Use, and Quality of Life in Individuals with Severe Haemophilia A Receiving Prophylaxis in a Prospective, Noninterventional Study JOURNAL OF CLINICAL MEDICINE
Resumen congreso2021 RESULTS FROM A 52-WEEK, PROSPECTIVE, NONINTERVENTIONAL STUDY OF INDIVIDUALS WITH SEVERE HAEMOPHILIA A RECEIVING PROPHYLAXIS: RATES OF BLEEDING, FVIII USE, AND QUALITY OF LIFE HAEMOPHILIA
Resumen congreso2021 RESULTS FROM A PHASE 1/2 SAFETY AND DOSE ESCALATION STUDY OF TAK-754, AN AAV8 VECTOR WITH A CODON-OPTIMIZED B-DOMAIN-DELETED FACTOR VIII TRANSGENE IN SEVERE HEMOPHILIA A HAEMOPHILIA
Letter2021 The factor VIII treatment history of non-severe hemophilia A: COMMENT. Joint damage in adult patients with mild or moderate hemophilia A evaluated with the HEAD-US system JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Artículo2021 Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project HAEMOPHILIA
Artículo2021 Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD-US system HAEMOPHILIA
Artículo2020 Adherence to prophylaxis in adult patients with severe haemophilia A HAEMOPHILIA
Artículo2020 BAY 81-8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study EUROPEAN JOURNAL OF HAEMATOLOGY
Resumen congreso2020 BAY 81-8973 PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA A: INTERIM FINDINGS FOR CHILDREN <12 YEARS FROM THE TAURUS REAL-WORLD STUDY HAEMOPHILIA
Resumen congreso2020 Caplacizumab As New Paradigm-Changing Therapy for Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (aTTP): Real-World Data from TTP Spanish Registry BLOOD
Resumen congreso2020 DETERMINATION OF THE CHALLENGES AND OPPORTUNITIES ASSOCIATED WITH PLATELET TRANSFUSION IN THE MANAGEMENT OF PATIENTS WITH SEVERE THROMBOCYTOPENIA ASSOCIATED WITH CHRONIC LIVER DISEASE HAEMATOLOGICA
Resumen congreso2020 Development of an observatory of unmet needs and future trends on the management of people with hemophilia in Spain HAEMOPHILIA
Resumen congreso2020 DONOR LYMPHOCYTE INFUSION: RETROSPECTIVE ANALYSIS OF EXPERIENCE AND UTILITY IN A THIRD-LEVEL HOSPITAL HAEMATOLOGICA
Resumen congreso2020 ELTROMBOPAG VS ROMIPLOSTIN IN THE TREATMENT OF IMMUNE THROMBOCYTOPENIA. PRACTICAL ASPECTS HAEMATOLOGICA
Resumen congreso2020 Evans' Syndrome in Adults: An Observational Multicentre Study BLOOD
Artículo2020 General concepts on hemophilia A and on women carrying the disease BLOOD COAGULATION & FIBRINOLYSIS
Resumen congreso2020 GRANULOCYTOAPHERESIS IN INFLAMMATORY BOWEL DISEASE: SAFETY AND EFFICACY HAEMATOLOGICA
Artículo2020 Management of chronic liver disease-associated severe thrombocytopenia in Spain: A view from the experts Revista Española de Enfermedades Digestivas
Resumen congreso2020 PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS HAEMOPHILIA
Resumen congreso2020 PK-guided switch from standard half-life to extended half-life factor VIII products HAEMOPHILIA
Artículo2020 Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain EUROPEAN JOURNAL OF HAEMATOLOGY
Resumen congreso2020 SPANISH REGISTRY OF PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA. ANALYSIS OF PATIENTS TREATED WITH CAPLACIZUMAB HAEMATOLOGICA
Resumen congreso2020 TEN YEARS OF EXPERIENCE IN THE TREATMENT OF PTT IN A THIRD LEVEL HOSPITAL HAEMATOLOGICA
Resumen congreso2020 THE HAEMOPHILIA OBSERVATORY IN SPAIN. A ROADMAP TOWARDS SHARED VALUE IN HAEMOPHILIA HEALTHCARE FROM A MULTIDISCIPLINARY AND PATIENT-ORIENTED PERSPECTIVE VALUE IN HEALTH
Artículo2020 Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort THROMBOSIS AND HAEMOSTASIS
Resumen congreso2019 Adherence to prophylaxis in adult patients with severe haemophilia A HAEMOPHILIA
Artículo2019 Clinical pattern of hemophilia and causes of variability BLOOD COAGULATION & FIBRINOLYSIS
Resumen congreso2019 Clinical results of continuous prophylaxis in patients with severe haemophilia after change in factor VIII of extended average lifespan HAEMATOLOGICA
Resumen congreso2019 Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products BLOOD
Artículo2019 Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia Scientific reports
Resumen congreso2019 Determinants of prophylaxis regimen choice for patients with haemophilia A switching to BAY 81-8973: Real-world findings from the TAURUS non-interventional study HAEMOPHILIA
Resumen congreso2019 DETERMINING THE EPIDEMIOLOGY, PATIENT FLOW, TREATMENT AND UNMET NEEDS OF PATIENTS WITH CHRONIC LIVER DISEASE-ASSOCIATED SEVERE THROMBOCYTOPENIA UNDERGOING INVASIVE PROCEDURES IN SPAIN VALUE IN HEALTH
Resumen congreso2019 Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study BLOOD
Resumen congreso2019 Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group BLOOD
Resumen congreso2019 Influence of Age on Treatment with Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia; A Retrospective Multicenter Study BLOOD
Artículo2019 Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients BLOOD COAGULATION & FIBRINOLYSIS
Artículo2019 Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group. Advances in hematology
Artículo2019 Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content PLATELETS
Resumen congreso2019 Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up BLOOD
Resumen congreso2019 PREDICTORS OF TREATMENT FREE RESPONSES WITH THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH PTI HAEMATOLOGICA
Resumen congreso2019 SPANISH REGISTRY OF ACQUIRED HEMOPHILIA, 5 YEARS OF ACTIVITY HAEMATOLOGICA
Resumen congreso2019 SWITCH ANALYSIS GUIDED BY PHARMACOKINETICS FROM FACTORS VIII OF STANDARD HALF LIFE TO EXTENDED HALF LIFE FACTORS HAEMATOLOGICA
Resumen congreso2019 TAURUS real-world study: Straightforward transition to BAY 81-8973 prophylaxis in patients with haemophilia A with maintained or reduced dosing frequency HAEMOPHILIA
Resumen congreso2019 THROMBOTIC EVENTS IN PATIENTS WITH PTI TREATED WITH THROMBOPOIETIN RECEPTOR AGONISTS. IDENTIFICATION OF PREDISPOSING FACTORS HAEMATOLOGICA
Artículo2019 Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA HAEMATOLOGICA
Revisión2019 Update on Molecular Testing in von Willebrand Disease SEMINARS IN THROMBOSIS AND HEMOSTASIS
Artículo2018 Análisis de costes del tratamiento para pacientes con hemofilia A con inhibidor en España Analysis of treatment costs for hemophilia A patients with inhibitor in Spain Pharmacoeconomics - Spanish Research Articles
Resumen congreso2018 Determinants of Prophylaxis Regimen Choice for Patients with Hemophilia A Switching to Bay 81-8973: Real World Findings from the Taurus Non-Interventional Study BLOOD
Artículo2018 Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT® HAEMOPHILIA
Capítulo2018 Inhibidores adquiridos de la coagulación Hemostasia y trombosis: manual práctico
Resumen congreso2018 Lymphoma under hospitalized chemotherapy schemes: Specific Thromboembolic Risk Factors and Venous thrombosis incidence THROMBOSIS RESEARCH
Letter2018 Moderate and severe haemophilia in Spain: An epidemiological update HAEMOPHILIA
Artículo2018 Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project PLOS ONE
Resumen congreso2018 Safety and efficacy of fascial therapy in the treatment of hemophilic arthropathy of elbow: a pilot study HAEMOPHILIA
Resumen congreso2018 Straightforward Transition to Bay 81-8973 Prophylaxis in Patients with Hemophilia A: Prospective Real-World Data from the Taurus Non-Interventional Study Show That Number of Infusions per Week Is Maintained or Reduced BLOOD
Artículo2018 The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Artículo2018 Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia BLOOD COAGULATION & FIBRINOLYSIS
Libro2018 Trombosis y hemostasia: XII curso de formación continuada Trombosis y hemostasia: XII curso de formación continuada
Revisión2017 Acquired haemophilia: Epidemiology, clinical presentation, diagnosis and treatment MEDICINA CLINICA
Resumen congreso2017 BYPASSING AGENTS PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA AND INHIBITORS UNDERGOING SURGERY: A DECISION ANALYSIS IN SPAIN VALUE IN HEALTH
Artículo2017 Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study Hematology
Artículo2017 Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A THROMBOSIS AND HAEMOSTASIS
Resumen congreso2017 COMBINED TREATMENT OF AZATHIOPRINE AND ROMIPLOSTIM IN PATIENTS ITP REFRACTORY TO STEROIDS OR THROMBOPOIETIN ANALOGS HAEMATOLOGICA
Resumen congreso2017 Influence of Inhibitor Characteristics on Response to Hemostatic and Immunosuppressive Treaments in Acquired Hemophilia Patients: The Ciha Project BLOOD
Artículo2017 Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients HAEMATOLOGICA
Artículo2017 Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case series HAEMOPHILIA
Resumen congreso2017 Outpatients with Lymphoma on Chemotherapy: Specific Thromboembolic Risk Factors and Venous Thrombosis Incidence BLOOD
Resumen congreso2017 REAL WORLD EVIDENCE ON DRUG UTILIZATION PATTERNS OF ELTROMBOPAG IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIA: REVIEU (REVOLADE™ [ELTROMBOPAG] IN SELECTED COUNTRIES IN THE EUROPEAN UNION) STUDY HAEMATOLOGICA
Resumen congreso2017 Successful Treatment of Bleeding in Acquired Hemophilia A with Activated Prothrombin Complex Concentrate in Spain BLOOD
Artículo2017 Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain CASE REPORTS IN HEMATOLOGY
Resumen congreso2016 Characterization of Bleeding in Hemophilia Carriers and Comparison to Women with Type 1 Von Willebrand Disease, Type 3 Von Willebrand Disease Obligate Carriers and Controls BLOOD
Artículo2016 Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study HAEMOPHILIA
Letter2016 FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studies HAEMOPHILIA
Artículo2016 Hip Replacement Surgery in 14-Year-Old Girl with Factor V Deficiency: Haemostatic Treatment and Thromboprophylaxis CASE REPORTS IN HEMATOLOGY
Resumen congreso2016 Improved Clinical Outcomes and Replacement FVIII Consumption in Patients with Hemophilia a after Prophylaxis Adjustment Using a FVIII Pharmacokinetics Estimation Based on Bayesian Models BLOOD
Artículo2016 Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm THROMBOSIS AND HAEMOSTASIS
Revisión2016 Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors EUROPEAN JOURNAL OF HAEMATOLOGY
Artículo2016 Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors THROMBOSIS AND HAEMOSTASIS
Artículo2015 Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A HAEMOPHILIA
Artículo2015 Adult severe haemophilia A patients under long-term prophylaxis with factor VIII in routine clinical practice BLOOD COAGULATION & FIBRINOLYSIS
Artículo2015 Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain HAEMOPHILIA
Artículo2015 Coste por paciente con respuesta a romiplostim y rituximab en el tratamiento de la trombocitopenia inmune primaria en España MEDICINA CLINICA
Resumen congreso2015 Efficacy and Safety of Eltrombopag in Persistent and Newly Diagnosed ITP BLOOD
Artículo2015 Inhibitor development in non-severe haemophilia across Europe THROMBOSIS AND HAEMOSTASIS
Artículo2015 Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year survey HAEMOPHILIA
Artículo2015 Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia AMERICAN JOURNAL OF HEMATOLOGY
Artículo2015 Use of eltrombopag after romiplostim in primary immune thrombocytopenia BRITISH JOURNAL OF HAEMATOLOGY
Resumen congreso2015 Validation of the international society on thrombosis and haemostasis bleeding assessment tool (ISTH-BAT) in hemophilia carriers JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2014 Analysis of Bleeding Phenotype of Severe Hemophilia a Carriers and Comparation with a Working Population Group. Impact on Quality of Life BLOOD
Resumen congreso2014 Analysis of Hemorrhagic Phenotype and Cardiovascular Risk of Severe Hemophilia a Carriers and Difference with Female Working Population Control Group BLOOD
Resumen congreso2014 Application of Pharmacokinetics Programs in Optimization of Haemostatic Treatment in Severe Hemophilia a Patients: Changes in Consumption, Clinical Outcomes and Quality of Life BLOOD
Artículo2014 Comparación de guías internacionales sobre púrpura trombocitopénica autoinmunitaria primaria MEDICINA CLINICA
Resumen congreso2014 Indication, Resource Consumption and Clinical Outcomes of Prophylaxis in Adult Patients with Severe Hemophilia a in Routine Clinical Practice BLOOD
Revisión2014 Key issues in inhibitor management in patients with haemophilia BLOOD TRANSFUSION
Resumen congreso2014 Primary Immune Thrombocytopenia in Elderly Patients: Clinical Profile, Efficacy and Safety of Treatment Protocols BLOOD
Resumen congreso2014 Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia BLOOD
Resumen congreso2014 Use of Eltrombopag after Romiplostim in Primary ITP Patients BLOOD
Resumen congreso2014 Validation of the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) in Hemophilia Carriers HAEMOPHILIA
Resumen congreso2013 AURIGA: study of adherence to prophylaxis in patients with severe haemophilia A JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2013 Comprehensive assessment of hemorrhagic phenotype and cardiovascular risk profile in carriers of severe haemophilia JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Artículo2013 Consenso nacional sobre el diagnóstico, estratificación de riesgo y tratamiento de los pacientes con tromboembolia pulmonar ARCHIVOS DE BRONCONEUMOLOGIA
Resumen congreso2013 Cost analysis of bypassing agent prophylaxis treatment versus on-demand therapy in hemophilia A with inhibitor in Spain VALUE IN HEALTH
Resumen congreso2013 First-LINE Treatment With High-Dose Dexamethasone Terapy For Adult Primary Inmune Thrombocytopenia BLOOD
Revisión2013 Global Emerging HEmophilia Panel (GEHEP): A Multinational Collaboration for Advancing Hemophilia Research and Treatment TRANSFUSION MEDICINE AND HEMOTHERAPY
Resumen congreso2013 Inhibitor characterization in acquired haemophilia and its influence on bleeding profiles and treatment response: CIHA-01 project JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2013 Registry of inhibitors in mild and moderate haemophilia A patients in Spain JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2013 Thrombopoietin Analogs In ITP Patients Daily Practice: Treatment Profile, Efficacy and Safety BLOOD
Resumen congreso2012 APLASTIC ANEMIA IN PATIENTS OVER 60 YEARS OLD: EFFECTIVENESS AND SAFETY OF TREATMENT PROFILES HAEMATOLOGICA
Resumen congreso2012 Aplastic Anemia: Effectiveness and Safety of Treatment Profiles Depending On Age BLOOD
Artículo2012 Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Editorial2012 Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria MEDICINA CLINICA
Artículo2012 Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) BLOOD
Artículo2012 Is on-demand treatment effective in patients with severe haemophilia? HAEMOPHILIA
Artículo2012 Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry BLOOD
Artículo2012 Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
Letter2012 The international factor IX treatment network survey HAEMOPHILIA
Resumen congreso2011 Dexamethasone vs. standard prednisone in patients with chronic ITP: results and preferences JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2011 Intracranial bleeding in patients with haemophilia and inhibitors JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Artículo2011 Prophylaxis therapy in haemophilia A: current situation in Spain HAEMOPHILIA
Resumen congreso2011 Splenectomy, rituximab and romiplostim in chronic ITP: efficacy and safety profile JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Artículo2010 Consensus recommendations for the diagnosis and treatment of acquired hemophilia A BMC Research Notes
Resumen congreso2010 Iliopsoas hematoma in patients with hemophilia and inhibitor HAEMOPHILIA
Resumen congreso2010 Integral assessment of hemophilia carriers: new guideline from Spanish Foundation Victoria Eugenia HAEMOPHILIA
Resumen congreso2010 Integral physiotherapeutic guidelines for hemophilia patients from Spanish Foundation Victoria Eugenia HAEMOPHILIA
Resumen congreso2010 Optimum response to treatment of immunotolerance with octocog alfa HAEMOPHILIA
Resumen congreso2010 Pharmacologic venous thromboembolism prophylaxis in haemophilic patients under major orthopaedic surgery: experience and safety profile HAEMOPHILIA
Artículo2010 Romiplostim: un gran avance en el tratamiento de la purpura trombocitopenica idiopatica METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
Resumen congreso2010 The Spanish Immune Tolerance Induction Registry: 2009 update HAEMOPHILIA
Resumen congreso2009 Evaluation of secondary prophylaxis with rfviia in hemophiliac patients with inhibitors JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2009 Hemophiliac patient serum bank: evaluation of the influence of emerging pathogens and infectious risks associated to replacement therapy after 2 years follow-up JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2009 How can the right FVIII dosage to neutralise low titre inhibitor be calculated? JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2009 Impact of FVIII product change in severe haemophilia A patients previously treated with plasma-derived FVIII JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2009 Integral assessment of female hemophilia carriers JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Revisión2009 International recommendations on the diagnosis and treatment of patients with acquired hemophilia A HAEMATOLOGICA
Resumen congreso2009 Primary prophylaxis with recombinant factor VIIa (rFVIIa) in eleven haemophilia a patients with inhibitors younger than 3 years old JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Resumen congreso2008 Pharmacokinetics of FVIII in clinical practice:: resource optimization and effect on health and quality of life in hemophilia A HAEMOPHILIA
Artículo2004 Control of Epstein-Barr virus load and lymphoproliferative disease by maintenance of CD8+ T lymphocytes in the T lymphocyte-depleted graft after bone marrow transplantation JOURNAL OF INFECTIOUS DISEASES
Resumen congreso1999 Mixed chimerism detected by VNTR-PCR is associated with a high incidence of relapse after selective CD4+ depletion plus adjusted CD8+ T-cell content in BMT BONE MARROW TRANSPLANTATION
Resumen congreso1998 Analysis of hematopoietic chimerism by VNTR-PCR after allogeneic bone marrow transplantation for acute leukemia BLOOD
Fenotipo hemostático en mujeres portadoras de hemofilia A: características del perfil hemorrágico y el riesgo cardiovascular. Repercusión en la calidad de vida relacionada con la salud (2016)
Dirigida por: Miguel Ángel Sánchez Chaparro, Pedro Valdivielso Felices
Este investigador no ha dirigido/tutorizado tesis
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado